SCHEMBL7187916

SCHEMBL7187916

COC(=O)CCC(I)B(O)OC(C)(C)C(C)(C)O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 1/20 0.36
TSHR P16473 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5838024 0.74
SCHEMBL7179667 0.74 CYP2D6 (0.34)
SCHEMBL7185923 0.72 SMN1; SMN2 (0.34) SLC1A1TSHRL3MBTL1
SCHEMBL5837322 0.69
SCHEMBL9244038 0.63 TSHR (0.52) SLC1A1TSHRL3MBTL1
SCHEMBL5837790 0.62
SCHEMBL16329096 0.62 TSHR (0.50) SLC1A1TSHRL3MBTL1
SCHEMBL83790 0.62 TSHR (0.50) SLC1A1TSHRL3MBTL1
SCHEMBL7645747 0.61
SCHEMBL3757520 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586615-B1 Boron compounds such as 1-amino-3,3-difluoropropyl boronate pinacol ester used as intermediates for antagonists of serine proteases, leukocyte elastases, cathepsins, chymotrypsin and hepatitis virus enzyme inhibitors BRISTOL-MYERS SQUIBB COMPANY 2003-07-01 US disclosed
WO-2002054931-A2 ALPHA-AMINOBORONIC ACIDS PREPARED BY NOVEL SYNTHETIC METHODS BRISTOL MYERS SQUIBB COMPANY P (US) 2002-07-18 WO disclosed
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed